Menu ×

HEALTHCARE & PHARMACEUTICAL

Hematopoietic Stem Cell Transplant (HPSCT) Market Segmentation by Transplant Type (Allogeneic, and Autologous); by Application {Peripheral Blood Stem Cell Transplant (PBSCT), Bone Marrow Transplant (BMT), and Cord Blood Transplant (CBT)}; by Disease Indication (Lymphoproliferative Disorders, Leukemia, and Non-Malignant Disorders); by End User (Hospitals, and Specialty Centers) – Global Demand Analysis & Opportunity Outlook 2029

  • Text Size:

Extensive insights into the Growth of Hematopoietic Stem Cell Transplant Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Global Hematopoietic Stem Cell Transplant (HPSCT) Market Highlights 2020 – 2029

The hematopoietic stem cell transplant (HPSCT) market is expected to grow with a substantial CAGR over the forecast period, i.e., 2021 – 2029. The increasing prevalence of hematopoietic disorders and the high success rate of transplants are the major factors that are expected to boost the growth of the market. As per our analysis, more than 129,000 people in the United States are evaluated to be diagnosed with a serious blood disorder in 2021.  Apart from that, the rise in the ageing population across the globe is also a significant contributor to the growth of this market. According to the United Nations Organisation, by the end of 2050, every 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019. Furthermore, with advancements in lifesaving technologies, the global hematopoietic stem cell transplant market size is projected to witness a rapid and steady expansion over the forecast period.

Global-Hematopoietic-Stem-Cell-Transplant-Market

On the basis of transplant type, the market is segmented into allogeneic and autologous segments. The allogeneic transplant type segment is estimated to hold the largest market share in 2021 and is expected to continue this trend throughout the forecast period. Allogeneic stem cell transplantation involves the process of transfer of stem cells from a donor other than the patient. One of the major benefits of this process is that the patient who has undergone the transplantation process creates a new immune system after the donated cells are engrafted into the patient’s body. However, the demand for autologous transplants is expected to grow significantly during the forecast period on account of the lack of availability of donors for allogeneic transplantation. By application, the bone marrow transplant segment is anticipated to grow with a significant CAGR on the back of growing R&D in the field of healthcare and the vast variety of diseases treated by this procedure. CLICK TO DOWNLOAD SAMPLE REPORT

Global Hematopoietic Stem Cell Transplant Market Regional Analysis

On the basis of geographical analysis, the global hematopoietic stem cell transplant market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American hematopoietic stem cell transplant market is anticipated to grab the leading position in terms of market share by the end of 2021 as a result of the rising demand for better treatment options and the increasing occurrence of leukemia and lymphoma. The data from National Cancer Institute depicts that the estimated number of new cases of leukemia in the United States in 2020 was 60,530, which accounts for about 3.4% of all the new cancer cases. Apart from these, the market growth in this region can also be attributed to the high investments in research and development for developing effective treatment for hematopoietic disorders. On the other hand, the market in Europe is also anticipated to grab a considerable share in the market owing to the overall increase in the success rate of transplants, a technologically advanced healthcare system, and a high-income population.

Global-Hematopoietic-Stem-Cell-Transplant-Market-Size

The global hematopoietic stem cell transplant market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global hematopoietic stem cell transplant market includes the following segments:

By Transplant type

  • Allogeneic
  • Autologous

By Application

  • Peripheral Blood Stem Cell Transplant (PBSCT)
  • Bone Marrow Transplant (BMT)
  • Cord Blood Transplant (CBT)

By Disease Indication

  • Lymphoproliferative Disorders
    • Plasma Cell Disorders
    • Hodgkin Lymphoma
    • Others
  • Leukemia
    • Acute Myeloid Leukemia (AML)
    • Acute Lymphatic Leukemia (ALL)
    • Myelodysplastic Syndrome (MDS)
    • Others
  • Non-Malignant Disorders
    • Bone Marrow Failure
    • Hemoglobinopathies
    • Autoimmune Diseases
    • Others

By End User

  • Hospitals
  • Specialty Centers

Growth Drivers

  • Rising Incidences of Leukemia and Lymphoma
  • Increasing Research on Hematopoietic Stem Cells

Restraints

  • High Stem Cell Transplant Treatment Cost
  • Difficulty in Finding a Donor

Top Featured Companies Dominating the Market

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved